The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Purdue Pharma and the Sackler family that own the company have agreed to a $7.4 billion settlement in principle with 15 ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its ...

Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families." ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.